First Capital Advisors Group, Llc. Moderna, Inc. Transaction History
First Capital Advisors Group, Llc.
- $188 Million
- Q2 2023
A detailed history of First Capital Advisors Group, Llc. transactions in Moderna, Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 152 shares of MRNA stock, worth $17,642. This represents 0.01% of its overall portfolio holdings.
Number of Shares
152Holding current value
$17,642% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MRNA
# of Institutions
1,040Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.18 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.53 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.95 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.68 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.12 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...